Age-specific Parkinson disease risk in GBA mutation carriers: Information for genetic counseling

Genetics in Medicine

Volumn 15, Issue 2, 2013, Pages 146-149

  Rana, Huma Q ^a   Balwani, Manisha ^a   Bier, Louise ^a   Alcalay, Roy N ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

family history; Gaucher disease; GBA mutations; glucocerebrosidase; Parkinson disease; risk

Indexed keywords

GLUCOSYLCERAMIDASE;

ADULT; AGED; ARTICLE; ENZYME REPLACEMENT; ETHNICITY; FAMILY HISTORY; FEMALE; GAUCHER DISEASE; GENE MUTATION; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; GRANDPARENT; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; ONSET AGE; PARENT; PARKINSON DISEASE; PENETRANCE; SPLENECTOMY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FAMILY HEALTH; FEMALE; GAUCHER DISEASE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GLUCOSYLCERAMIDASE; HETEROZYGOTE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MUTATION; PARKINSON DISEASE; PENETRANCE; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84873564795     PISSN: 10983600     EISSN: 15300366     Source Type: Journal    
DOI: 10.1038/gim.2012.107     Document Type: Article

References (18)

1. Scott SA, Edelmann L, Liu L, Luo M, Desnick RJ, Kornreich R. Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases. Hum Mutat 2010;31:1240-1250.
2. Sidransky E, Nalls MA, Aasly JO, et al. Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 2009;361:1651-1661.
3. Neudorfer O, Giladi N, Elstein D, et al. Occurrence of Parkinson's syndrome in type I Gaucher disease. QJM 1996;89:691-694.
4. Rosenbloom B, Balwani M, Bronstein JM, et al. The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry. Blood Cells Mol Dis 2011;46:95-102.
5. Lwin A, Orvisky E, Goker-Alpan O, LaMarca ME, Sidransky E. Glucocerebrosidase mutations in subjects with parkinsonism. Mol Genet Metab 2004;81:70-73.
6. Aharon-Peretz J, Rosenbaum H, Gershoni-Baruch R. Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. N Engl J Med 2004;351:1972-1977.
7. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E. The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 2008;65:1353-1357.
8. Halperin A, Elstein D, Zimran A. Increased incidence of Parkinson disease among relatives of patients with Gaucher disease. Blood Cells Mol Dis 2006;36:426-428.
9. Mitsui J, Mizuta I, Toyoda A, et al. Mutations for Gaucher disease confer high susceptibility to Parkinson disease. Arch Neurol 2009;66:571-576.
10. Giraldo P, Capablo JL, Alfonso P, et al. Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence? J Inherit Metab Dis 2011;34:781-787.
11. Kalinderi K, Bostantjopoulou S, Paisan-Ruiz C, Katsarou Z, Hardy J, Fidani L. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Greece. Neurosci Lett 2009;452:87-89.
12. Bras J, Paisan-Ruiz C, Guerreiro R, et al. Complete screening for glucocerebrosidase mutations in Parkinson disease patients from Portugal. Neurobiol Aging 2009; 30:1515-1517.
13. Anheim M, Elbaz A, Lesage S, et al. Penetrance of Parkinson disease in glucocerebrosidase gene mutation carriers. Neurology 2012;78:417-420.
14. Marder K, Levy G, Louis ED, et al. Accuracy of family history data on Parkinson's disease. Neurology 2003;61:18-23.
15. Gross SJ, Pletcher BA, Monaghan KG; Professional Practice and Guidelines Committee. Carrier screening in individuals of Ashkenazi Jewish descent. Genet Med 2008;10:54-56.
16. Marder K, Levy G, Louis ED, et al. Familial aggregation of early-and late-onset Parkinson's disease. Ann Neurol 2003;54:507-513.
17. McNeill A, Duran R, Hughes DA, Mehta A, Schapira AH. A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers. J Neurol Neurosurg Psychiatry 2012;83:853-854.
18. de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology 2004;63:1240-1244.